cytokeratin 19 fragment in serum; CYFRA 21-1 in serum
Jump to navigation
Jump to search
Indications
- evaluation of prognosis & monitoring of non-small cell lung cancer
Clinical significance
- elevated pretreatment levels may be associated with unfavorable prognosis
- decreasing levels during therapy predict an objective response to treatment
More general terms
Additional terms
- biomarkers for lung cancer screening
- keratin, type I cytoskeletal 19; cytokeratin-19; CK-19; keratin-19; K19 (KRT19)
Component of
References
- ↑ ARUP Consult: CYFRA 21-1 (Cytokeratin 19 Fragment) in Lung Cancer https://arupconsult.com/ati/cyfra-21-1-cytokeratin-19-fragment-lung-cancer